Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Myocarditis and pericarditis after vaccination for COVID-19.

5 Aug, 2021 | 08:57h | UTC

Myocarditis and Pericarditis After Vaccination for COVID-19 – JAMA

Related:

Analysis finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis.

CDC: Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients – “Continued use of mRNA COVID-19 vaccines in all recommended age groups will prevent morbidity and mortality from COVID-19 that far exceed the number of cases of myocarditis expected”.

Case Series: Myocarditis following immunization with mRNA COVID-19 vaccines.

CDC: mRNA vaccines are likely linked to cases of myocarditis and pericarditis – 1,226 cases of myocarditis or pericarditis have been reported mostly in people under 30.

 

RCT: Similar outcomes with Milrinone vs. Dobutamine in the treatment of cardiogenic shock.

5 Aug, 2021 | 08:44h | UTC

Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock – New England Journal of Medicine (link to abstract – $ for full-text)

Visual abstract: Milrinone vs. Dobutamine in Cardiogenic Shock

Commentary: Inotrope Showdown Leaves No Winner in Cardiogenic Shock – MedPage Today (link to abstract – $ for full-text)

 

Position statement: Perioperative management of post-COVID-19 surgical patients.

4 Aug, 2021 | 10:00h | UTC

Perioperative management of post-COVID-19 surgical patients: Indian Society of Anaesthesiologists (ISA National) Advisory and Position Statement – Indian Journal of Anaesthesia

Related:

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

WSES Position Paper: The management of surgical patients in the emergency setting during COVID-19 pandemic

Preparing previously COVID-19-positive patients for elective surgery: A framework for preoperative evaluation

 

Commentary on Twitter

 

Clinical practice recommendations on the management of perioperative cardiac arrest.

4 Aug, 2021 | 09:03h | UTC

Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium – Critical Care

 

SCAI expert consensus update on best practices in the cardiac catheterization laboratory.

4 Aug, 2021 | 09:04h | UTC

SCAI expert consensus update on best practices in the cardiac catheterization laboratory – Catheterization & Cardiovascular Interventions

Commentary: SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory: Optimizing Quality of Care – American College of Cardiology

Related:

AHA Scientific Statement: Evidence-based practices in the cardiac catheterization laboratory.

 

RCT: Midodrine can reduce the recurrence of vasovagal syncope.

4 Aug, 2021 | 08:54h | UTC

Midodrine for the Prevention of Vasovagal Syncope: A Randomized Clinical Trial – Annals of Internal Medicine

Commentary: Midodrine Cuts Recurrent Syncope in Young, Healthy Patients – HealthDay

Summary for patients: Summary for Patients: Midodrine to Prevent Fainting – Annals of Internal Medicine

 

Commentary on Twitter

 

AHA Scientific Statement: Considerations for cardiovascular genetic and genomic research with marginalized racial and ethnic groups and indigenous peoples.

3 Aug, 2021 | 02:24h | UTC

Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association – Circulation

News release: New statement provides path to include ethnicity, ancestry, race in genomic research – American Heart Association

 

M-A: Association between adiposity and cardiovascular outcomes.

3 Aug, 2021 | 02:11h | UTC

Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies – European Heart Journal

 

Commentary on Twitter

 

2021 Update in the diagnosis and management of acute coronary syndromes for the perioperative clinician.

3 Aug, 2021 | 02:22h | UTC

2021 Update in the Diagnosis and Management of Acute Coronary Syndromes For the Perioperative Clinician – Journal of Cardiothoracic and Vascular Anesthesia

 

Commentary on Twitter

https://twitter.com/AlejandroLemor/status/1418925354870349826

 

Subgroup analysis of RCT suggests early rhythm control therapy is beneficial for patients with atrial fibrillation and heart failure.

3 Aug, 2021 | 02:00h | UTC

Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure – Circulation

Original study: #ESCCongress – [Abstract Only] Randomized trial: Early rhythm-control therapy in patients with atrial fibrillation (study and commentaries)

Related:

Meta-Analysis: Catheter Ablation Improves Outcomes in Patients with Atrial Fibrillation Complicated with Heart Failure

Catheter Ablation for Atrial Fibrillation Improves Outcomes in Heart Failure with Reduced Ejection Fraction

M-A: In patients with atrial fibrillation, catheter ablation was associated with a 38% reduction in recurrence and a 68% reduction in hospitalizations. The rate of serious complications was 4.2% with ablation vs. 2.8% in the antiarrhythmic group, a difference that was not statistically significant.

CABANATrial: Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

 

Ten things to know about ten imaging studies: A preventive cardiology perspective.

2 Aug, 2021 | 00:12h | UTC

Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”) – American Journal of Preventive Cardiology

 

AHA Scientific Statement: Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions.

2 Aug, 2021 | 00:17h | UTC

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association – Circulation

Top Things to Know: Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions – American Heart Association

Commentary: The Need for Improved Identification and Treatment of Peripheral Arterial Disease – American Heart Association

 

Assessment and management of peripheral arterial disease: what every cardiologist should know.

2 Aug, 2021 | 00:15h | UTC

Assessment and management of peripheral arterial disease: what every cardiologist should know – Heart

 

Commentary on Twitter

https://twitter.com/Heart_BMJ/status/1417391335246553094

 

Ten things to know about ten cardiovascular disease risk factors.

2 Aug, 2021 | 00:11h | UTC

Ten things to know about ten cardiovascular disease risk factors – American Journal of Preventive Cardiology

 

Does this adult patient have hypertension? the rational clinical examination systematic review.

2 Aug, 2021 | 00:05h | UTC

Does This Adult Patient Have Hypertension? The Rational Clinical Examination Systematic Review – JAMA (free for a limited period)

 

Risk of acute myocardial infarction and ischemic stroke following COVID-19 in Sweden – “the true risk is increased by between three and eight times for acute myocardial infarction and by between three and seven times for ischaemic stroke following COVID-19.”

30 Jul, 2021 | 12:06h | UTC

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study – The Lancet

Invited commentary: What is the association of COVID-19 with heart attacks and strokes? – The Lancet

 

Commentary on Twitter

 

Brazilian Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation – 2021.

30 Jul, 2021 | 11:54h | UTC

Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation – 2021 – Arquivos Brasileiros de Cardiologia (PDF)

 

Donor drug use is not associated with worse recipient survival in heart transplantation – “Increasing use of such donors may help alleviate the chronic donor shortage.”

30 Jul, 2021 | 11:39h | UTC

Intoxicated Donors and Heart Transplant Outcomes: Long-Term Safety – Circulation: Heart Failure

Commentary: Donor Drug Use Not Tied to Survival for Heart Transplant Recipients – HealthDay

Related study: National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts? – Circulation: Heart Failure

 

20-year observational study suggests return to play is manageable for most athletes with Long QT Syndrome or genetic heart diseases.

30 Jul, 2021 | 11:40h | UTC

News release: 20-year study suggests return to play is manageable for athletes with most genetic heart diseases – Mayo Clinic

Original study: Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries:

Return to Play Seems Safe for Most Athletes With Long QT Syndrome – HealthDay

Return-to-Play for Athletes With LQTS or Genetic Heart Diseases – American College of Cardiology

 

Commentary on Twitter

 

ESC Position Paper: Cardiac, renal, and metabolic effects of SGLT2 inhibitors.

29 Jul, 2021 | 11:13h | UTC

Cardiac, renal, and metabolic effects of sodium–glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium–glucose co-transporter 2 inhibitors – European Journal of Heart Failure

 

Review: Lipoprotein(a) and Cardiovascular Diseases.

29 Jul, 2021 | 10:56h | UTC

Lipoprotein(a) and Cardiovascular Diseases – JAMA (free for a limited period)

 

ESC Consensus Document: Antithrombotic therapies in aortic and peripheral arterial diseases in 2021.

28 Jul, 2021 | 09:56h | UTC

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy – European Heart Journal

Key Points to remember: ESC Consensus on Antithrombotic Therapies in Aortic and Peripheral Artery Diseases – American College of Cardiology

 

Commentary on Twitter

 

Expert consensus: Multimodality imaging of myocardial viability.

28 Jul, 2021 | 09:46h | UTC

Multimodality imaging of myocardial viability: an expert consensus document from the European Association of Cardiovascular Imaging (EACVI) – European Heart Journal – Cardiovascular Imaging

Related: Review | Myocardial perfusion and viability imaging in coronary artery disease: clinical value in diagnosis, prognosis and therapeutic guidance.

 

Commentary on Twitter

 

Review: A pathophysiological compass to personalize antianginal drug treatment.

27 Jul, 2021 | 03:27h | UTC

A pathophysiological compass to personalize antianginal drug treatment – Nature Reviews Cardiology (free for a limited period)

 

Commentary on Twitter

 

AHA Report: Recommendations for statistical reporting in cardiovascular medicine.

27 Jul, 2021 | 03:22h | UTC

Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association – Circulation

 

Commentary on Twitter (thread – click for more)

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.